Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2021 Feb:41:436-438.
doi: 10.1016/j.clnesp.2020.12.011. Epub 2021 Jan 7.

Magnesium and imidazole propionate

Affiliations
Randomized Controlled Trial

Magnesium and imidazole propionate

Lei Fan et al. Clin Nutr ESPEN. 2021 Feb.

Abstract

Background & aims: Circulating levels of imidazole propionate (ImP), a microbial metabolite of histidine, were higher in participants with type 2 diabetes (T2D) compared to those without and also induced insulin resistance. We hypothesize that low intake of magnesium (Mg) and/or low body Mg status in humans may lead to low Mg concentrations in gut microbiota, and, in turn, elevated microbial production of ImP and increased levels of circulating ImP.

Methods: We tested this hypothesis in the Personalized Prevention of Colorectal Cancer Trial (PPCCT) (registered at clinicaltrials.gov as NCT01105169), a double-blind 2 × 2 factorial randomized controlled trial enrolling 240 participants at high risk of Mg deficiency. Among 68 participants (34 each in the treatment and placebo arms), we measured plasma metabolites using the untargeted Metabolon's global Precision Metabolomics™ LC-MS platform.

Results: Mg treatment significantly reduced ImP by 39.9% compared to a 6.0% increase in the placebo arm (P = 0.02). We found the correlation coefficients were -0.12 (P = 0.32) and -0.31 (P < 0.01) between the change in ImP and changes in serum Mg and urinary Mg, respectively. In addition, we found Mg treatment increased circulating levels of propionic acid (InP) by 27.5% (P = 0.07) and reduced levels of glutarate by 17.9% (P = 0.04) compared to the placebo arm.

Conclusions: Further studies are needed to replicate these findings and to investigate whether Mg treatment specifically changes the production of ImP by microbiota. Also, future studies are warranted to confirm the effect of Mg treatment on glutarate and InP.

Keywords: Imidazole propionate; Magnesium; Microbial metabolite; Randomized controlled trial; Type 2 diabetes.

PubMed Disclaimer

Conflict of interest statement

Declaration of competing interest All authors have no conflicts of interest.

References

    1. Koh A, Molinaro A, Ståhlman M, Khan MT, Schmidt C, Mannerås-Holm L, et al. Microbially Produced Imidazole Propionate Impairs Insulin Signaling through mTORC1. Cell 2018;175:947–961.e17. 10.1016/j.cell.2018.09.055. - DOI - PubMed
    1. Koh A, Mannerås-Holm L, Yunn N-O, Nilsson PM, Ryu SH, Molinaro A, et al. Microbial Imidazole Propionate Affects Responses to Metformin through p38γ-Dependent Inhibitory AMPK Phosphorylation. Cell Metab 2020. 10.1016/j.cmet.2020.07.012. - DOI - PMC - PubMed
    1. Menni C, Zhu J, Le Roy CI, Mompeo O, Young K, Rebholz CM, et al. Serum metabolites reflecting gut microbiome alpha diversity predict type 2 diabetes. Gut Microbes 2020;11:1632–42. 10.1080/19490976.2020.1778261. - DOI - PMC - PubMed
    1. Bender RA. Regulation of the histidine utilization (hut) system in bacteria. Microbiol Mol Biol Rev 2012;76:565–84. 10.1128/MMBR.00014-12. - DOI - PMC - PubMed
    1. Kumarevel T, Mizuno H, Kumar PKR. Structural basis of HutP-mediated anti-termination and roles of the Mg2+ ion and L-histidine ligand. Nature 2005;434:183–91. 10.1038/nature03355. - DOI - PubMed

Publication types

Associated data